News

On May 7, 2021, the NMPA issued the notice regarding the transition from old to new platforms for cosmetics registration and filing.

In accordance with the CSAR, the NMPA addressed the details of the information needed to support the application of cosmetics registration and filing.

The first edition of the new IECIC list was last updated in 2015 and now covers 8792 cosmetic ingredients.

5 new technical medical device guidelines whilst there were 4 guidelines implemented and 6 drafts are announced by NMPA

The Center for Medical Device Standardization Administration issued the notice to solicitate proposals for amending medical device standards in China

The NMPA is currently soliciting public comments on the draft documents. The public consultation period is open until May 30, 2021.

883 commodities were announced under the MFN Rate of Duty whilst the import tariff rate on artificial heart valve, hearing aids, etc., reduced from 4% to 1%

The China NIFDC announced the technical guidelines (draft) for Radio Frequency beauty devices to be regulated as class II or class III medical devices.

Our testing engineers are specialized in EMC (Electro Magnetic Compatibility), electrical safety, physical and chemical property and biocompatibility tests.

Identifying the key trends, market opportunities and latest regulatory updates of the digital healthcare sector in China and relevant regulatory framework.

The China GAC issued 2 administrative measures for the safety of imported and exported food products and for the registration of overseas manufacturers.

The NIFDC launched a public consultation to solicit comments on prohibiting CBD and other ingredients for cosmetics in China.

The NMPA published a Q&A article to relieve the concerns of the cosmetics industry on the registration and filing procedures in China.

This is an important guidance in the framework of the new cosmetics regulations that came into force at the start of 2021.

The China NMPA technical guidelines for cosmetic safety assessment (2021 Edition) will come into effect from May 1, 2021, onwards.

The NMPA announced various measures for cosmetic registration and filing information management to support the implementation of the CSAR.

9 product categories have been reported by the NMPA for not meeting the standard requirements whilst 12 regulatory guidelines and drafts have been issued.

According to the announcement published by the Centre for Medical Device Evaluation) of the National Medical Products Administration on April 12, 2021...

The announcement cover details of the working procedures and appendices for quality spot checks and inspection procedures for medical devices within China.

Inspection work shall be carried out in accordance with the mandatory standards or product technical requirements for post-market activities in China.